We are live on ! Find out more
AVNS

Avanos Medical
AVNS

Delisted

AVNS was delisted on the 24th of July, 2026.

Back to rankings

468 hedge funds and large institutions have $1.6B invested in Avanos Medical in 2014 Q4 according to their latest regulatory filings, with 468 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

18% less call options, than puts

Call options by funds: $7.47M | Put options by funds: $9.08M

Holders
468
Holders Change
+468
Holders Change %
–
% of All Funds
12.48%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
468
Increased
–
Reduced
–
Closed
–
Calls
$7.47M
Puts
$9.08M
Net Calls
-$1.61M
Net Calls Change
-$1.61M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$125M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$112M
3
GC
Greenlight Capital
New York
+$92.5M
4
RP
RR Partners
New York
+$74.7M
5
BIT
BlackRock Institutional Trust
California
+$74.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SF
226
Synovus Financial
Georgia
$347K +$295K +7,511 New
SCM
227
Shelton Capital Management
Colorado
$331K +$286K +7,283 New
Barclays
228
Barclays
United Kingdom
$328K +$287K +7,296 New
Verition Fund Management
229
Verition Fund Management
Connecticut
$326K +$281K +7,165 New
CIM
230
Calvert Investment Management
Maryland
$324K +$280K +7,128 New
EARNEST Partners
231
EARNEST Partners
Georgia
$320K +$276K +7,029 New
RCYC
232
Richard C. Young & Co
Rhode Island
$320K +$277K +7,043 New
AIP
233
Ameritas Investment Partners
Nebraska
$318K +$275K +7,000 New
BOH
234
Bank of Hawaii
Hawaii
$311K +$269K +6,847 New
CAM
235
Capstone Asset Management
Texas
$308K +$267K +6,784 New
Truist Financial
236
Truist Financial
North Carolina
$307K +$266K +6,768 New
IP
237
Isthmus Partners
Wisconsin
$305K +$264K +6,718 New
DekaBank Deutsche Girozentrale
238
DekaBank Deutsche Girozentrale
Germany
$305K +$279K +7,113 New
CA
239
CapWealth Advisors
Tennessee
$298K +$258K +6,556 New
SAM
240
Securian Asset Management
Minnesota
$295K +$255K +6,490 New
OA
241
OFI Advisors
Pennsylvania
$288K +$248K +6,323 New
Squarepoint
242
Squarepoint
New York
$282K +$244K +6,200 New
Susquehanna International Group
243
Susquehanna International Group
Pennsylvania
$282K +$244K +6,211 New
ACM
244
Azimuth Capital Management
Michigan
$274K +$236K +6,016 New
BAM
245
Berkshire Asset Management
Pennsylvania
$273K +$236K +5,999 New
SMC
246
Smith, Moore & Co
Missouri
$271K +$234K +5,962 New
DC
247
Davenport & Co
Virginia
$263K +$227K +5,777 New
WF
248
Welch & Forbes
Massachusetts
$261K +$225K +5,737 New
VOYA Investment Management
249
VOYA Investment Management
Georgia
$259K +$224K +5,706 New
KIC
250
Keating Investment Counselors
Florida
$256K +$221K +5,627 New
8 9
10
11 12

AVNS Hedge Fund Activity: Q4 2014 in Review

468 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2014, worth a combined $1.6B.

Buyers outnumbered sellers: 468 funds opened new AVNS positions and 0 closed out — a net gain of 468 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $125M.

  • 468 institutional investors held Avanos Medical (AVNS) as of Q4 2014, up from 0 in Q3 2014.
  • Funds reported $1.6B of Avanos Medical stock for Q4 2014.
  • 468 funds opened new Avanos Medical positions in Q4 2014 and 0 closed out, a net change of +468 holders.
  • The largest Avanos Medical buyer in Q4 2014 was T. Rowe Price Associates, an estimated $125M added.

Based on aggregated 13F filings for Q4 2014.